BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 11028110)

  • 1. The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations.
    Dumitriu-Stan RI; Burcea IF; Nastase VN; Ceaușu RA; Dumitrascu A; Cocosila LC; Bastian A; Zurac S; Raica M; Poiana C
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plurihormonal Pituitary Neuroendocrine Tumors: Clinical Relevance of Immunohistochemical Analysis.
    Dumitriu-Stan RI; Burcea IF; Dobre R; Nastase VN; Ceausu RA; Raica M; Poiana C
    Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience.
    Voznyak O; Zinkevych I; Lytvynenko A; Hryniv N; Ilyuk R; Kobyliak N
    Rev Recent Clin Trials; 2024 Mar; ():. PubMed ID: 38561622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic SF3B1 hotspot mutation in prolactinomas.
    Li C; Xie W; Rosenblum JS; Zhou J; Guo J; Miao Y; Shen Y; Wang H; Gong L; Li M; Zhao S; Cheng S; Zhu H; Jiang T; Ling S; Wang F; Zhang H; Zhang M; Qu Y; Zhang Q; Li G; Wang J; Ma J; Zhuang Z; Zhang Y
    Nat Commun; 2020 May; 11(1):2506. PubMed ID: 32427851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plurihormonal PIT1-lineage pituitary neuroendocrine tumors: a clinicopathological study].
    Duan ZJ; Feng J; Zhao HQ; Wang HD; Gui QP; Zhang XF; Ma Z; Hu ZJ; Xiang L; Qi XL
    Zhonghua Bing Li Xue Za Zhi; 2023 Oct; 52(10):1017-1024. PubMed ID: 37805393
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinicopathological Characteristics of Plurihormonal Pituitary Adenoma.
    Shi R; Wan X; Yan Z; Tan Z; Liu X; Lei T
    Front Surg; 2022; 9():826720. PubMed ID: 35284477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter to the Editor from Andereggen and Christ: "Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study".
    Andereggen L; Christ E
    J Clin Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38843072
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to Letter to the Editor from Andereggen and Christ: "Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study".
    Wang L; Zhu H
    J Clin Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38843073
    [No Abstract]   [Full Text] [Related]  

  • 9. Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study.
    Bima C; Chiloiro S; Giampietro A; Gessi M; Mattogno PP; Lauretti L; Anile C; Rindi G; Pontecorvi A; De Marinis L; Bianchi A
    Front Endocrinol (Lausanne); 2021; 12():684055. PubMed ID: 34322092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary prolactin-secreting tumor formation: recent developments.
    Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
    Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary Hyperplasia, Hormonal Changes and Prolactinoma Development in Males Exposed to Estrogens-An Insight From Translational Studies.
    Šošić-Jurjević B; Ajdžanović V; Miljić D; Trifunović S; Filipović B; Stanković S; Bolevich S; Jakovljević V; Milošević V
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative immunohistochemical analysis of estrogen receptor and chromogranin-A reactivity in plurihormonal human prolactinomas.
    Talan-Hranilović J; Gnjidić Z; Sajko T; Vizner B; Vrkljan M
    Acta Med Croatica; 2000; 54(2):59-63. PubMed ID: 11028110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W; Ikeda H; Yoshimoto T
    Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different expression of chromogranin A and chromogranin B in various types of pituitary adenomas.
    Riva C; Leutner M; Capella C; Usellini L; la Rosa S; Brianza MR; Buffa R
    Zentralbl Pathol; 1993 Jun; 139(2):165-70. PubMed ID: 8396420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.